Pharming Group N.V. Files 6-K with Press Release
Ticker: PHAR · Form: 6-K · Filed: Apr 30, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, sec-filing
TL;DR
Pharming Group N.V. dropped a 6-K filing with a press release on April 30, 2025.
AI Summary
Pharming Group N.V. filed a Form 6-K on April 30, 2025, to furnish a press release dated April 30, 2025. The press release, filed as Exhibit 99.1, is the primary content of this filing. No specific financial figures or operational details were provided in the header information.
Why It Matters
This filing indicates that Pharming Group N.V. is providing updated information to the SEC, likely related to recent business developments or announcements that are material to investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a press release and does not contain new financial data or significant operational changes that would inherently increase risk.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- 001-39822 (dollar_amount) — SEC File Number
- April 30, 2025 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release dated April 30, 2025, as Exhibit 99.1.
What is the SEC file number for Pharming Group N.V.?
The SEC file number for Pharming Group N.V. is 001-39822.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on April 30, 2025.
What is the principal executive office address of Pharming Group N.V.?
The principal executive office address of Pharming Group N.V. is Darwinweg 24, 2333 CR Leiden, The Netherlands.
Does Pharming Group N.V. file annual reports under Form 20-F?
Yes, Pharming Group N.V. indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2025 regarding Pharming Group N.V. (PHAR).